News

Alnylam to Webcast Conference Call Discussing First Quarter 2025 Financial Results
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the first quarter ending March 31, 2025 on Thursday, May ...
Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Growth Stock to Buy According to Billionaires?
We recently published a list of 10 Best Growth Stocks to Buy According to Billionaires. In this article, we are going to take ...
High Growth Tech Stocks In US With Potential For Expansion
The United States market is currently experiencing a mixed performance with major indexes such as the Dow Jones and S&P 500 showing modest gains, while the tech-heavy Nasdaq Composite has seen slight ...
Alnylam price target lowered to $268 from $284 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Alnylam (ALNY) to $268 from $284 and keeps an Equal Weight rating on the shares. The firm is ...
Morgan Stanley Keeps Their Hold Rating on Alnylam Pharma (ALNY)
In a report released today, Michael Ulz from Morgan Stanley maintained a Hold rating on Alnylam Pharma (ALNY – Research Report), with a price ...